Helpline 07939 046 030
Freephone 0300 102 17 22*

Bea’s Story: Courage and Resilience

02 March 2026

Bea's 12th birthday

Bea was diagnosed with Neurofibromatosis Type 1 (NF1) when she was five years old, following a life threatening seizure when she stopped breathing, which resulted in her being airlifted to hospital and placed in an induced coma, in intensive care, for three days. 

When she was unconscious, the doctors looking after her noticed the cafe-au-lait marks and auxiliary freckling on her body. Following further tests and an MRI, it was established that Bea also has Lisch nodules in her eyes and a change in the white matter in her brain, which confirmed the diagnosis clinically before it was confirmed genetically from blood tests some time later.

This was a spontaneous mutation, as is the case with half of NF patients, as no one in our family had any history of the condition. Bea now has a 50:50 chance of passing it on to her own children.

Bea went on to have three further prolonged seizures, all requiring medication, emergency admissions, and overnight stays in hospital. After further tests, Bea was diagnosed as being photosensitive, as well as epileptic (one of the associated conditions that can occur with NF1), and is now on daily anti-seizure medication, which thankfully seems to have controlled her seizures.

Bea continues to have regular check-ups for her NF, and in 2021 was diagnosed with scoliosis and subsequently, an unusually rotated pelvis, which has sadly progressed to a point where Bea will need to have major spinal surgery.

Spinal surgery tends to be problematic in NF patients because of the weakness of the bones. Bea’s surgery is made even more complicated as she was found to have an extensive inoperable plexiform neurofibroma in her lumbar region, so has been referred to the Complex NF Clinic at Guy’s Hospital in London, and will be under their care for life.

Bea is extremely small and physically very immature for her age. She will never be as tall as she would have been without having NF and scoliosis, but she will have a growth spurt in due course, and that is when her progressive scoliosis could really cause a problem as it is likely that she will curve more at her periods of rapid growth.

Bea has been fitted with a full body brace to try to control the progression of the curve as she grows. She wears the brace for around 20 hours per day. It is extremely uncomfortable and she is in a lot of pain and very tired with it, but early signs suggest it is definitely helping to reduce the degree to which Bea curves as she grows, which is great news. 

The decision was made that it would be more beneficial for Bea to wear the brace to try to give her chance to grow taller, stronger and older before she has to endure what is pretty horrific major surgery. 

This extremely complex, rare, major spinal surgery, where it is highly likely that her spine will be fused from both the front and the back, also necessitates the need to move organs. This is to give Bea’s bones the best chance to fuse so that her supportive metalwork does not break. 

Bea and sister Bonnie

In anterior surgeries, it is preferred to enter from the left but this is not possible with Bea as her tumour is on her left side and she curves to the right, where it is more tricky to navigate past the organs. After the anterior part of the surgery, Bea will then be opened posteriorly and also fused from the back. The recovery time for this major all-day spinal fusion is approximately a year, but it has been decided that this is the better way forward to hopefully reduce the overall number of surgeries which Bea has to endure. 

The cardio investigations for Bea’s proposed surgery also showed that she has a small hole in her heart as well as a faulty mitral valve, both of which conditions need monitoring. 

Bea suffers with constant pain, both musculoskeletal pain from the scoliosis and more acute nerve pain from the tumour, as well as the general unexplained pain of NF, which is in her legs, tummy, and back. 

She had some mild learning difficulties and problems with speech development and pronunciation, which required speech therapy - all further hallmarks of NF.

In spite of all this pain, adversity, bad news, and depressing diagnoses of conditions and complications without an easy treatment or cure (or none at all), Bea has remained the most delightful, positive, stoical, brave, modest, happy and cheerful little girl, who is known by all as someone who never stops smiling, and who never lets these setbacks dampen her mood or outlook on life. Beatrice means “Bringer of Joy’ and she could not have been given a more perfect name, as that is what she does every single day. 

Bea has an older sister, Bonnie, who takes her big sister responsibilities extremely seriously and is so loving and caring towards Bea. They are very close indeed.

Bea and Bonnie in 2025

When Bea was diagnosed with NF1, we were told to contact Nerve Tumours UK for the most accurate and non-sensationalised information to try to understand what might lie ahead for Bea, rather than searching the internet.

The charity offers invaluable support and advice for patients, families, and teachers with all aspects of living with NF. We are eternally grateful that Bea’s family, friends, teachers and so many people around her have also become very much aware of this relatively rare condition, and have learnt so much about it in order to support and understand Bea, and the challenges she and other NF sufferers face.

Fyling Fest Fundraiser

Our family has supported Nerve Tumours UK since Bea’s diagnosis and they have supported us. I have spoken to Rebecca as well as Rachael in the North East, and Carolyn Smyth. From being diagnosed with a condition of which we were previously utterly unaware, and have subsequently had to learn all there is to know, Nerve Tumours UK has always been there to offer measured and extremely informed advice and reassurance in what has been, at times, a bewildering journey. 

We are very grateful for all the work they do to support those affected by NF in such a huge variety of ways, throughout the challenges the condition presents at all stages of life, and we are proud to continue to support the wonderful work that the charity does. 

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK